ellipticine and kanamycin a

ellipticine has been researched along with kanamycin a in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dettrakul, S; Kittakoop, P; Rajviroongit, S; Surerum, S1
Kongsaeree, P; Mongkolvisut, W; Prabpai, S; Sutthivaiyakit, S1
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P1

Other Studies

3 other study(ies) available for ellipticine and kanamycin a

ArticleYear
Biomimetic transformation and biological activities of Globiferin, a terpenoid benzoquinone from Cordia globifera.
    Journal of natural products, 2009, May-22, Volume: 72, Issue:5

    Topics: Antifungal Agents; Antimalarials; Antitubercular Agents; Benzoquinones; Biotransformation; Candida albicans; Cordia; Drug Resistance, Multiple; Inhibitory Concentration 50; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Plant Roots; Plants, Medicinal; Plasmodium falciparum; Terpenes; Thailand

2009
Diterpenes, sesquiterpenes, and a sesquiterpene-coumarin conjugate from Jatropha integerrima.
    Journal of natural products, 2009, Volume: 72, Issue:11

    Topics: Animals; Antimalarials; Antineoplastic Agents, Phytogenic; Antitubercular Agents; Chlorocebus aethiops; Coumarins; Crystallography, X-Ray; Diterpenes; Drug Resistance, Microbial; Drug Screening Assays, Antitumor; Jatropha; Microbial Sensitivity Tests; Molecular Conformation; Molecular Structure; Mycobacterium tuberculosis; Plant Roots; Plants, Medicinal; Plasmodium falciparum; Sesquiterpenes; Thailand

2009
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
    Bioorganic & medicinal chemistry, 2012, Nov-15, Volume: 20, Issue:22

    Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship

2012